PRIMTRACEUTICALS
PRIMTRACEUTICALS
Aktie · CA74167D2041 · A2QB3W (XCNQ)
Übersicht
Kein Kurs
n/a
Asset Allocation
VermögenswertAnteil %
Stock US83,66 %
Stock non-US16,83 %
NotClassified0,00 %
Other0,00 %
Bond0,00 %
Cash-0,49 %
Die größten Positionen
SymbolISINNameAnteil %
ZSZscaler Inc 7,63 %
FTNTFortinet Inc 7,47 %
CRWDCrowdStrike Holdings Inc 6,55 %
PANWPalo Alto Networks Inc 5,61 %
CHKPCheck Point Software Technologies Ltd 5,43 %
CYBRCyberArk Software Ltd 5,15 %
OKTAOkta Inc 5,14 %
RPDRapid7 Inc 5,11 %
AVSTAvast Plc 5,08 %
NLOKNortonLifeLock Inc 4,85 %
Regionenverteilung
RegionAnteil %
North America83,71 %
Africa/Middle East5,40 %
Japan5,38 %
United Kingdom5,05 %
Asia Developed0,47 %
Asia Emerging0,00 %
Australasia0,00 %
Europe Developed0,00 %
Europe Emerging0,00 %
Latin America0,00 %
Sektorverteilung
SektorAnteil %
Technologie100,00 %
Grundstoffe0,00 %
Verbrauchsgüter0,00 %
Finanzdienstleistungen0,00 %
Immobilien0,00 %
Telekommunikation0,00 %
Energie0,00 %
Industrieunternehmen0,00 %
Basiskonsumgüter0,00 %
Gesundheitswesen0,00 %
Firmenprofil zu PRIMTRACEUTICALS Aktie
Primo Nutraceuticals Inc. owns and develops commercial real estate properties for the cannabis cultivation sector in Canada. It offers built out turnkey facilities equipped with infrastructure to cannabis growers and processors. It owns hemp project in Oregon state and the greenhouse campus in Washington state. The company was formerly known as Bougainville Ventures Inc. and changed its name to Primo Nutraceuticals Inc. in October 2019. Primo Nutraceuticals Inc. was incorporated in 2014 and is based in Vancouver, Canada.
Erhalte tagesaktuelle Insights vom finAgent über PRIMTRACEUTICALS
Fonds-Stammdaten
Emittent Global X Management
Wertpapierart ETF
Name Global X Funds - Global X Cybersecurity ETF
Fondswährung USD
Kategorie Technology
Fonds-Kennzahlen
Fondsgröße 662.787,71 EUR
Anlagestrategie
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Cybersecurity Index. The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from increased adoption of cybersecurity technology. The fund is non-diversified.

Unternehmensdaten

Name PRIMTRACEUTICALS
Firma Primo Nutraceuticals Inc.
Website https://www.primonutraceuticals.com
Heimatbörse XCNQ CSE LISTED
WKN A2QB3W
ISIN CA74167D2041
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Richard Cindric
Land Kanada
Währung EUR
Mitarbeiter -
Adresse 890 West Pender Street, V6C 1J9 Vancouver
IPO Datum 2019-04-22

Ticker Symbole

Name Symbol
Over The Counter BUGVF
Weitere Aktien
Investoren, die PRIMTRACEUTICALS halten, haben auch folgende Aktien im Depot:
AMERICAN SHIPPING C10
AMERICAN SHIPPING C10 Aktie
ASML HOLDING
ASML HOLDING Aktie
CELLECTAR BIOSCIENCES INC
CELLECTAR BIOSCIENCES INC Aktie
ESPORTS ENTERTAINMENT GROUP INC
ESPORTS ENTERTAINMENT GROUP INC Aktie
LYXOR S+P SMALLCAP ETF I
LYXOR S+P SMALLCAP ETF I ETF
NEWDAY FUNDING 2018-2 PLC CLASS D AB FRN 15/12/2026 (144A)
NEWDAY FUNDING 2018-2 PLC CLASS D AB FRN 15/12/2026 (144A) Anleihe
NVIDIA CORP
NVIDIA CORP Aktie
ORYZON GENOMICS SA EO-,05
ORYZON GENOMICS SA EO-,05 Aktie
PALANTIR TECHNOLOGIESLOGIES INC CLASS A
PALANTIR TECHNOLOGIESLOGIES INC CLASS A Aktie
SEA LTDR)/1
SEA LTDR)/1 Hinterlegungsschein
SOFTBANK GROUP CORP
SOFTBANK GROUP CORP Aktie
TENCENT . LTD
TENCENT . LTD Aktie
THUERINGEN LS 21/51
THUERINGEN LS 21/51 Anleihe
XIAOMI CORP CL.B
XIAOMI CORP CL.B Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025